Literature DB >> 15107480

Monitoring denaturation behaviour and comparative stability of DNA triple helices using oligonucleotide-gold nanoparticle conjugates.

Deirdre Murphy1, Ramon Eritja, Gareth Redmond.   

Abstract

Gold nanoparticle labels, combined with UV-visible optical absorption spectroscopic methods, are employed to probe the temperature-dependent solution properties of DNA triple helices. By using oligonucleotide-nanoparticle conjugates to characterize triplex denaturation, for the first time triplex to duplex melting transitions may be sensitively monitored, with minimal signal interference from duplex to single strand melting, for both parallel and antiparallel triple helices. Further, the comparative sequence-dependent stability of DNA triple helices may also be examined using this approach. Specifically, triplex to duplex melting transitions for triplexes formed using oligonucleotides that incorporate 8-aminoguanine derivatives were successfully monitored and stabilization of both parallel and antiparallel triplexes following 8-aminoguanine substitutions is demonstrated.

Entities:  

Mesh:

Substances:

Year:  2004        PMID: 15107480      PMCID: PMC407843          DOI: 10.1093/nar/gnh065

Source DB:  PubMed          Journal:  Nucleic Acids Res        ISSN: 0305-1048            Impact factor:   16.971


  30 in total

1.  DNA-triplex stabilizing properties of 8-aminoguanine.

Authors:  R Soliva; R Güimil García; J R Blas; R Eritja; J L Asensio; C González; F J Luque; M Orozco
Journal:  Nucleic Acids Res       Date:  2000-11-15       Impact factor: 16.971

2.  Unique condensation patterns of triplex DNA: physical aspects and physiological implications.

Authors:  Rivka Goobes; Orit Cohen; Abraham Minsky
Journal:  Nucleic Acids Res       Date:  2002-05-15       Impact factor: 16.971

3.  Resolution of parallel and antiparallel oligonucleotide triple helices formation and melting processes by multivariate curve resolution.

Authors:  J Jaumot; A Aviña; R Eritja; R Tauler; R Gargallo
Journal:  J Biomol Struct Dyn       Date:  2003-10

4.  Triple helix stabilization properties of oligonucleotides containing 8-amino-2'-deoxyguanosine.

Authors:  R Güimil García; A Bachi; R Eritja; F J Luque; M Orozco
Journal:  Bioorg Med Chem Lett       Date:  1998-11-03       Impact factor: 2.823

Review 5.  Triplex DNA: fundamentals, advances, and potential applications for gene therapy.

Authors:  P P Chan; P M Glazer
Journal:  J Mol Med (Berl)       Date:  1997-04       Impact factor: 4.599

6.  A fluorescence-based method for determining the surface coverage and hybridization efficiency of thiol-capped oligonucleotides bound to gold thin films and nanoparticles.

Authors:  L M Demers; C A Mirkin; R C Mucic; R A Reynolds; R L Letsinger; R Elghanian; G Viswanadham
Journal:  Anal Chem       Date:  2000-11-15       Impact factor: 6.986

7.  Solution structure of an antiparallel purine motif triplex containing a T.CG pyrimidine base triple.

Authors:  J Ji; M E Hogan; X Gao
Journal:  Structure       Date:  1996-04-15       Impact factor: 5.006

8.  Triple helix formation by oligopurine-oligopyrimidine DNA fragments. Electrophoretic and thermodynamic behavior.

Authors:  G Manzini; L E Xodo; D Gasparotto; F Quadrifoglio; G A van der Marel; J H van Boom
Journal:  J Mol Biol       Date:  1990-06-20       Impact factor: 5.469

9.  Effect of 5-methylcytosine on the stability of triple-stranded DNA--a thermodynamic study.

Authors:  L E Xodo; G Manzini; F Quadrifoglio; G A van der Marel; J H van Boom
Journal:  Nucleic Acids Res       Date:  1991-10-25       Impact factor: 16.971

10.  Solution structure of a purine.purine.pyrimidine DNA triplex containing G.GC and T.AT triples.

Authors:  I Radhakrishnan; D J Patel
Journal:  Structure       Date:  1993-10-15       Impact factor: 5.006

View more
  1 in total

1.  Targeting duplex DNA with chimeric α,β-triplex-forming oligonucleotides.

Authors:  N A Kolganova; A K Shchyolkina; A V Chudinov; A S Zasedatelev; V L Florentiev; E N Timofeev
Journal:  Nucleic Acids Res       Date:  2012-05-27       Impact factor: 16.971

  1 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.